From ProPublica: The pharmaceutical company has deployed a potent new ally to justify skyrocketing drug prices. Precision Health Economics, a firm comprised of leading economists and health care experts from the nation’s top universities, is contracted by pharmaceutical companies to publish research showing that high drug prices are necessary for innovation.
